facebook
linkedin
twitter
About Us
  • BFSI
  • Energy
  • Infocom
  • Mining
  • Venture
  • Industry
  • Travel
  • Civic
  • Food, Health, Ag
  • Real Estate
  • Responsibility
  • Economy
  • Law & Justice
  • Interview
  • Analysis

Boston Biotech Company Immunotrex Biologics to Conduct Anti-Sepsis Clinical Trial in Colombia

Posted OnAugust 31, 2016
By :Jared Wade
Comment: Off
Tag: Biotech, boston, Clinical Trials, Immunotrex Biologics, interventional concepts, JSS Research

Boston-based biotech startup Immunotrex Biologics is partnering with research firm Interventional Concepts on an anti-sepsis compound clinical trial that it intends to hold in Colombia. The “Phase 0 human study” aims to analyze the effects of the compound in the human system and how the human body processes it.

Per the arrangement, Interventional Concepts will design the trial and chose the center and principal investigator in Colombia in conjunction with JSS Research, which is headquartered in Montreal, Canada. The pair will also coordinate the regulatory red tape and other necessary processes, or “tramites,” required to run such a study in Colombia.

The Andean nation has increasingly been making a name for itself in this sector and the government, through its ProColombia promotion arm, is now actively seeking more companies to host a Colombia clinical trial.

“Colombia is uniquely position to be the most cost-effective destination in Latin America for this type of clinical studies,” said Julio G. Martinez-Clark, president and CEO of Interventional Concepts. He added that, “we are proud of being part of the development of this breakthrough anti-sepsis compound.”

Immunotrex’s Colombia Clinical Trial

According to Immunotrex Biologics, sepsis, which is a life-threatening condition that can occur if a person’s immune system response to infection damages tissues and organs, is among the costliest healthcare expenses. In terms of in-patient cost in U.S. hospitals, it ran over $20 billion in 2011, with some 40% of patients who were diagnosed with severe sepsis dying.

“Until a cure for sepsis is found, early detection is the surest hope for survival,” said the company in a statement. “Up to 50% of survivors suffer from post-sepsis syndrome. In the U.S., sepsis is the second-leading cause of death in non-coronary ICU patients and the 10th-most-common cause of death overall.”

The company also stated that an average of three out of 1,000 people get severe sepsis, which leads to 215,000 deaths every year in the United States alone. Its clinical trial will focus on a series of therapeutic agents and compounds called KDEON that it developed along with researchers at the University of Massachusetts, Lowell. The remedy aims to neutralize and block the negative effects of endotoxins and other processes that contribute to sepsis.

“Immunotrex looks to fast track this crucial life-saving therapeutic into hospitals to save patients lives when facing septic shock,” said Syed K. Hasan, founder and CEO of Immunotrex Biologics.

DON'T MISS OUT: The only English-language Colombia news that's strictly business, markets, & investment!
Join global executives & investors by subscribing to our FREE weekly updates
I agree to have my personal information transferred to MailChimp ( more information ) DISCLAIMER: Protección de Datos Personales Artículo 15 de la Constitución Política de Colombia, ley 1581 de 2012 y decreto 1377 de 2013.
We will never spam you or share your email address ¡Nunca Jamás!

Share the news!

  • Facebook
  • Twitter
  • Print
  • Email
  • WhatsApp
  • LinkedIn
  • Skype

Related

Share your thoughts:

comments

Avatar
About the Author
Jared Wade is editor in chief of Finance Colombia. He is a Bogotá-based journalist with 15 years of experience covering topics including business, financial services, Latin America, and sports. Email him at jared.wade(at) financecolombia.com or follow him on Twitter at @Jared_Wade.
  • google-share
Previous Story

Colombian Coffee Federation Partners with Nespresso for Post-Conflict Development

Next Story

Aerotel Medical Systems Gets Regulatory Approval to Distribute ECG Devices in Colombia

Related Posts

Alejandro Calderón Chatet is the new CEO of Empresas Públicas de Medellín (EPM).
0

Alejandro Calderón Chatet Appointed CEO of EPM

Posted OnApril 6, 2021
, ByLoren Moss
American Airlines Boeing 777-200,
1

American Airlines Launches 3 Daily Routes Between NY and Cali, Bogotá, Medellín, Colombia

Posted OnFebruary 18, 2021
, ByLoren Moss
0

Interview: Management Guru Ram Charan On How Colombia Can Go From A Resource To A Knowledge-Based Economy

Posted OnJanuary 20, 2020
, ByLoren Moss




RECENT

POPULAR

COMMENTS

Tecnoglass window-making factory in Barranquilla, Colombia. (Photo credit: Liliana Padierna)

Tecnoglass To Hold Q1 2021 Earnings Call The Morning Of May 7

Posted On April 13, 2021

Etek Launches Identity & Access Management Service

Posted On April 13, 2021

GCA Airlines Files To Fly New Routes To Bucaramanga, Santa Marta, San Andrés & Pereira, Colombia

Posted On April 13, 2021
PharmaCielo horticultural worker harvests THC dominant and unique cultivar (CNW Group/PharmaCielo Ltd.)

Colombian Cannabis Cultivator PharmaCielo Closes $13.5 Million CAD Capital Raise

Posted On April 13, 2021
Photo from Twitter

Support for Colombian Fugitive Alex Saab Turns Out To Be Nigerian Troll Farm

Posted On April 13, 2021
Photo montage courtesy EPM

EPM’s Board of Directors Resign En Masse, Creating Crisis For Mayor Daniel Quintero

Posted On August 17, 2020

Court Blocks Colombia’s $370 Million USD Emergency Loan To Bankrupt Avianca Airlines

Posted On September 12, 2020

AVIANCA IS BANKRUPT

Posted On May 10, 2020

In Deepening Crisis At EPM, Labor Union Demands CEO Explain Private Gym, Luxury Office Remodel Despite Austerity Orders

Posted On August 25, 2020

Declan Ryan Says Viva Air Not Being Treated Fairly By Colombian Government: Exclusive Interview

Posted On September 3, 2020
Avatar

[…] 2020 — SINPRO, EPM’s largest...

Posted On April 12, 2021
Avatar

[…] Sky Airline each may operate 4...

Posted On April 6, 2021
Avatar

[…] didn’t know that; that...

Posted On April 6, 2021
Avatar

[…] during his mayoral campaign...

Posted On April 6, 2021
Avatar

[…] existing Viva aircraft are...

Posted On March 30, 2021

Watch This!

Book With Us

Consider Advertising With Us

Click here to visit Expat Group's English site

Subscribe Free

don't forget to include "http://"
* = required field
Your Background / Function








unsubscribe from list

RECENT

POPULAR

COMMENTS

Tecnoglass window-making factory in Barranquilla, Colombia. (Photo credit: Liliana Padierna)

Tecnoglass To Hold Q1 2021 Earnings Call The Morning Of May 7

Posted On April 13, 2021

Etek Launches Identity & Access Management Service

Posted On April 13, 2021

GCA Airlines Files To Fly New Routes To Bucaramanga, Santa Marta, San Andrés & Pereira, Colombia

Posted On April 13, 2021
Photo montage courtesy EPM

EPM’s Board of Directors Resign En Masse, Creating Crisis For Mayor Daniel Quintero

Posted On August 17, 2020

Court Blocks Colombia’s $370 Million USD Emergency Loan To Bankrupt Avianca Airlines

Posted On September 12, 2020
copa airlines

Copa Airlines Raising $350 Million USD War Chest Via Private Notes Offering

Posted On April 27, 2020
Avatar

[…] 2020 — SINPRO, EPM’s largest...

Posted On April 12, 2021
Avatar

[…] Sky Airline each may operate 4...

Posted On April 6, 2021
Avatar

[…] didn’t know that; that...

Posted On April 6, 2021

Watch This!

Contact Us (Click the image):

Book With Us

Pages

  • About Us
  • Colombia Events, Conferences, Festivals and Important Dates
  • Contact Us
  • main
  • Media Partnerships
  • Privacy Policy
  • Whatsapp test page
Copyright 2014-2020 Finance Colombia All Rights Reserved. We may earn commissions from qualifying purchases.
WhatsApp us
loadingCancel
Post was not sent - check your email addresses!
Email check failed, please try again
Sorry, your blog cannot share posts by email.